Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Melnick

Showing results (211-220 of 322) with videos related to

Pageof 33
Sort By:
International Review of Cell and Molecular Biology|January 26, 2025
DOGMA-seq and multimodal, single-cell analysis in acute myeloid leukemiaJangKeun Kim, Nathan Schanzer, Ruth Subhash Singh, et al.
Plos Biology|June 12, 2025
Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphomaOfir Griess, Noa Furth, Nofar Harpaz, et al.
Immunity|September 18, 2016
Multi-tiered Reorganization of the Genome during B Cell Affinity Maturation Anchored by a Germinal Center-Specific Locus Control RegionKaren L Bunting, T David Soong, Rajat Singh, et al.
Nature Communications|April 21, 2015
Epigenomic evolution in diffuse large B-cell lymphomasHeng Pan, Yanwen Jiang, Michela Boi, et al.
Oncotarget|July 16, 2014
Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cellsKyungsoo Ha, Warren Fiskus, Dong Soon Choi, et al.
Blood Cancer Discovery|February 3, 2025
Addressing Health Disparities in Hematologic Malignancies: from Genes to OutreachChristopher R Flowers, Rachel W Anantha, Veronica Leautaud, et al.
Nature Biotechnology|January 8, 2020
The therapeutic landscape for cells engineered with chimeric antigen receptorsMatthew MacKay, Ebrahim Afshinnekoo, Jonathan Rub, et al.
Cell Reports|July 11, 2019
MTA2/NuRD Regulates B Cell Development and Cooperates with OCA-B in Controlling the Pre-B to Immature B Cell TransitionXiangdong Lu, Chi-Shuen Chu, Terry Fang, et al.
Science Translational Medicine|January 27, 2017
CD99 is a therapeutic target on disease stem cells in myeloid malignanciesStephen S Chung, William S Eng, Wenhuo Hu, et al.
Molecular Cell|June 16, 2015
Engineering of a Histone-Recognition Domain in Dnmt3a Alters the Epigenetic Landscape and Phenotypic Features of Mouse ESCsKyung-Min Noh, Haibo Wang, Hyunjae R Kim, et al.
Pageof 33

Showing results (211-220 of 322) with videos related to

Sort By:
Pageof 33
International Review of Cell and Molecular Biology|January 26, 2025
DOGMA-seq and multimodal, single-cell analysis in acute myeloid leukemiaJangKeun Kim, Nathan Schanzer, Ruth Subhash Singh, et al.
Plos Biology|June 12, 2025
Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphomaOfir Griess, Noa Furth, Nofar Harpaz, et al.
Immunity|September 18, 2016
Multi-tiered Reorganization of the Genome during B Cell Affinity Maturation Anchored by a Germinal Center-Specific Locus Control RegionKaren L Bunting, T David Soong, Rajat Singh, et al.
Nature Communications|April 21, 2015
Epigenomic evolution in diffuse large B-cell lymphomasHeng Pan, Yanwen Jiang, Michela Boi, et al.
Oncotarget|July 16, 2014
Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cellsKyungsoo Ha, Warren Fiskus, Dong Soon Choi, et al.
Blood Cancer Discovery|February 3, 2025
Addressing Health Disparities in Hematologic Malignancies: from Genes to OutreachChristopher R Flowers, Rachel W Anantha, Veronica Leautaud, et al.
Nature Biotechnology|January 8, 2020
The therapeutic landscape for cells engineered with chimeric antigen receptorsMatthew MacKay, Ebrahim Afshinnekoo, Jonathan Rub, et al.
Cell Reports|July 11, 2019
MTA2/NuRD Regulates B Cell Development and Cooperates with OCA-B in Controlling the Pre-B to Immature B Cell TransitionXiangdong Lu, Chi-Shuen Chu, Terry Fang, et al.
Science Translational Medicine|January 27, 2017
CD99 is a therapeutic target on disease stem cells in myeloid malignanciesStephen S Chung, William S Eng, Wenhuo Hu, et al.
Molecular Cell|June 16, 2015
Engineering of a Histone-Recognition Domain in Dnmt3a Alters the Epigenetic Landscape and Phenotypic Features of Mouse ESCsKyung-Min Noh, Haibo Wang, Hyunjae R Kim, et al.
Pageof 33